Lipella Pharmaceuticals Eulerpool Ziņas

Lipella Pharmaceuticals Akciju Ziņas

Lipella Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Lipella Pharmaceuticals ziņas mēs apkopojam šeit.

• 20. jūnijs ·

  Yahoo
  Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
• 17. jūnijs ·

  Yahoo
  Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
• 4. jūnijs ·

  Yahoo
  Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development
• 11. februāris ·

  Yahoo
  Lipella Pharmaceuticals Shares Rise After Positive Phase 2a Trial Results for Oral Lichen Planus Treatment
• 3. decembris ·

  Yahoo
  Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
• 21. novembris ·

  Yahoo
  Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
• 17. novembris ·

  Yahoo
  Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023)
• 12. novembris ·

  Yahoo
  Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
• 3. novembris ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly
• 2. novembris ·

  Seeking Alpha
  Warning: LIPO is at high risk of performing badly